AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.

The FDA’s Center for Drug Evaluation and Research has accepted the first letter of intent for an in silico drug development tool into the agency’s Innovative Science and Technology Approaches for New ...

The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its ...

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...

(a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future ...

AsymBio’s Conjugation Toolbox supports customized process development across both random and site-specific conjugation ...

SOME PETS WERE RESCUED FROM HOMES. ALL NEW AT FIVE. AND FOR YOUR HEALTH, THE MEDICAL RESEARCHERS AT THE UNIVERSITY OF PITTSBURGH ARE AT IT AGAIN. THEY PUBLISHED RESEARCH LAST WEEK FOCUSING ON A WAY TO ...